BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Alios BioPharma 

260 East Grand Avenue
2nd Floor
South San Francisco  California  94080  U.S.A.
Phone: 650-635-5500 Fax: 650-872-0584


SEARCH JOBS




Industry
Biotechnology






 Company News
Alios BioPharma Reports Positive Results Of Its Anti-RSV Nucleoside Analog AL-8176 In A Phase 2 Challenge Study In Adults Infected With Respiratory Syncytial Virus (RSV) 7/24/2014 1:08:44 PM
South San Francisco's Alios BioPharma Raises $41 Million In Series B Financing 4/7/2014 10:57:52 AM
Alios BioPharma Reports Significant Progress With Its Clinical Program For AL-8176, Its Nucleoside Analog For The Treatment Of Respiratory Syncytial Virus (RSV) 1/13/2014 9:30:08 AM
Alios BioPharma Presented Data on Its First-in-Class Anti-Respiratory Syncytial Virus (RSV) Nucleoside Analogs at the 8th Annual Respiratory Syncytial Virus Symposium 10/1/2012 10:07:39 AM
Vertex Pharmaceuticals (MA) (VRTX) Vows to Fight on With Alios BioPharma Drugs in High-Stakes Hepatitis C Race 1/24/2012 7:24:04 AM
Vertex Pharmaceuticals (MA) (VRTX) and Alios BioPharma Begin Clinical Studies of Nucleotide Drug Candidates ALS-2200 and ALS-2158 for the Treatment of Hepatitis C 12/9/2011 6:51:43 AM
Alios BioPharma Signs Flu Treatment Deal with University of Hong Kong 10/31/2011 2:08:32 PM
U.S. Biotech Alios BioPharma and Versitech Ltd. Announce Exclusive Worldwide Licensing Agreement for Influenza Technology 10/31/2011 8:32:30 AM
Vertex Pharmaceuticals (MA) (VRTX) in Licensing Pact Potentially Worth $1.5 Billion With Alios BioPharma to Expand Hepatitis Pipeline 6/13/2011 7:59:34 AM
Alios BioPharma Names Carol L. Brosgart, M.D., as Chief Medical Officer 2/7/2011 8:31:04 AM
12